Humana (NYSE:HUM) Upgraded at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of Humana (NYSE:HUM – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday,Wall Street Zen reports.

Several other research analysts have also issued reports on HUM. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $249.00 to $370.00 in a research note on Tuesday, August 4th. Sanford C. Bernstein restated an “outperform” rating and issued a $425.00 target price on shares of Humana in a research note on Wednesday, June 3rd. TD Cowen increased their target price on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a report on Thursday, July 30th. Finally, Bank of America upgraded shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target on the stock in a research report on Wednesday, July 29th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $403.91.

Read Our Latest Research Report on Humana

Humana Stock Performance

NYSE:HUM opened at $378.02 on Friday. The firm has a market capitalization of $45.39 billion, a PE ratio of 35.76, a price-to-earnings-growth ratio of 2.39 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana has a 12-month low of $163.11 and a 12-month high of $428.88. The firm has a 50-day moving average price of $388.06 and a 200 day moving average price of $313.14.

Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.27 earnings per share. Research analysts anticipate that Humana will post 9 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s payout ratio is 33.49%.

Institutional Investors Weigh In On Humana

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HUM. Johnson Financial Group Inc. acquired a new stake in Humana during the 2nd quarter worth $26,000. Fideuram Asset Management Ireland dac acquired a new position in shares of Humana in the 4th quarter valued at approximately $27,000. Trust Co. of Vermont bought a new stake in Humana during the 2nd quarter worth approximately $28,000. Reflection Asset Management bought a new stake in Humana during the 4th quarter worth approximately $29,000. Finally, Bogart Wealth LLC raised its holdings in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

(Get Free Report)

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

Featured Stories